Clinical Trial Update: Long-term Safety and Efficacy Study of HSK44459 Tablets in Patients With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]

View source ↗

Summary

This clinical trial update notes a Phase 2 long-term safety and efficacy study of HSK44459 tablets in idiopathic pulmonary fibrosis, with recruitment not yet st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• HSK44459

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Idiopathic Pulmonary Fibrosis (IPF) | Phase 2 | Status: NOT_YET_RECRUITING